171 related articles for article (PubMed ID: 37953364)
1. The role of radiotherapy in tumor immunity and the potential of PET/CT in detecting the expression of PD-1/PD-L1.
Shen LF; Fu ZM; Zhou SH
Jpn J Radiol; 2024 Apr; 42(4):347-353. PubMed ID: 37953364
[TBL] [Abstract][Full Text] [Related]
2. Predictive value of 18F-fluorodeoxyglucose positron emission tomography/computed tomography for PD-L1 expression in non-small cell lung cancer: A systematic review and meta-analysis.
Seol HY; Kim YS; Kim SJ
Thorac Cancer; 2020 Nov; 11(11):3260-3268. PubMed ID: 32951338
[TBL] [Abstract][Full Text] [Related]
3. The Value of
Vekens K; Everaert H; Neyns B; Ilsen B; Decoster L
Clin Lung Cancer; 2021 Sep; 22(5):432-440. PubMed ID: 33879398
[TBL] [Abstract][Full Text] [Related]
4. Correlation of tumor-related immunity with 18F-FDG-PET in pulmonary squamous-cell carcinoma.
Kasahara N; Kaira K; Bao P; Higuchi T; Arisaka Y; Erkhem-Ochir B; Sunaga N; Ohtaki Y; Yajima T; Kosaka T; Oyama T; Yokobori T; Asao T; Nishiyama M; Tsushima Y; Kuwano H; Shimizu K; Mogi A
Lung Cancer; 2018 May; 119():71-77. PubMed ID: 29656756
[TBL] [Abstract][Full Text] [Related]
5. Metabolic characteristics of programmed cell death-ligand 1-expressing lung cancer on
Takada K; Toyokawa G; Okamoto T; Baba S; Kozuma Y; Matsubara T; Haratake N; Akamine T; Takamori S; Katsura M; Shoji F; Honda H; Oda Y; Maehara Y
Cancer Med; 2017 Nov; 6(11):2552-2561. PubMed ID: 28980429
[TBL] [Abstract][Full Text] [Related]
6. [Construction of A Nomogram Prediction Model for PD-L1 Expression
in Non-small Cell Lung Cancer Based on 18F-FDG PET/CT Metabolic Parameters].
Hao L; Wang L; Zhang M; Yan J; Zhang F
Zhongguo Fei Ai Za Zhi; 2023 Nov; 26(11):833-842. PubMed ID: 38061885
[TBL] [Abstract][Full Text] [Related]
7. A novel [
Puyalto A; Rodríguez-Remírez M; López I; Iribarren F; Simón JA; Ecay M; Collantes M; Vilalta-Lacarra A; Francisco-Cruz A; Solórzano JL; Sandiego S; Peñuelas I; Calvo A; Ajona D; Gil-Bazo I
Front Immunol; 2023; 14():1272570. PubMed ID: 37841258
[TBL] [Abstract][Full Text] [Related]
8. Associations of Tumor PD-1 Ligands, Immunohistochemical Studies, and Textural Features in
Chen RY; Lin YC; Shen WC; Hsieh TC; Yen KY; Chen SW; Kao CH
Sci Rep; 2018 Jan; 8(1):105. PubMed ID: 29311707
[TBL] [Abstract][Full Text] [Related]
9. Value of
Kaira K; Kuji I; Kagamu H
Cancer Imaging; 2021 Jan; 21(1):11. PubMed ID: 33441183
[TBL] [Abstract][Full Text] [Related]
10. 2-Deoxy-2-[fluorine-18] fluoro-d-glucose uptake on positron emission tomography is associated with programmed death ligand-1 expression in patients with pulmonary adenocarcinoma.
Kaira K; Shimizu K; Kitahara S; Yajima T; Atsumi J; Kosaka T; Ohtaki Y; Higuchi T; Oyama T; Asao T; Mogi A
Eur J Cancer; 2018 Sep; 101():181-190. PubMed ID: 30077123
[TBL] [Abstract][Full Text] [Related]
11. New insight on the correlation of metabolic status on
Wang Y; Zhao N; Wu Z; Pan N; Shen X; Liu T; Wei F; You J; Xu W; Ren X
Eur J Nucl Med Mol Imaging; 2020 May; 47(5):1127-1136. PubMed ID: 31502013
[TBL] [Abstract][Full Text] [Related]
12.
Kimura Y; Sasada S; Emi A; Masumoto N; Kadoya T; Arihiro K; Okada M
Anticancer Res; 2023 Jan; 43(1):127-136. PubMed ID: 36585209
[TBL] [Abstract][Full Text] [Related]
13. Tumor immunity is related to
Imai H; Kaira K; Hashimoto K; Nitanda H; Taguchi R; Yanagihara A; Umesaki T; Yamaguchi O; Mouri A; Kawasaki T; Yasuda M; Kobayashi K; Sakaguchi H; Kuji I; Kagamu H
Cancer Med; 2021 Sep; 10(18):6317-6326. PubMed ID: 34363337
[TBL] [Abstract][Full Text] [Related]
14. Predicting programmed death-ligand 1 (PD-L1) expression with fluorine-18 fluorodeoxyglucose ([
Hughes DJ; Josephides E; O'Shea R; Manickavasagar T; Horst C; Hunter S; Tanière P; Nonaka D; Van Hemelrijck M; Spicer J; Goh V; Bille A; Karapanagiotou E; Cook GJR
Eur Radiol; 2024 Feb; ():. PubMed ID: 38388716
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic test accuracy of
Seol HY; Kim YS; Kim SJ
Clin Radiol; 2021 Nov; 76(11):863.e19-863.e25. PubMed ID: 34261597
[TBL] [Abstract][Full Text] [Related]
16. Relationship between the expression of PD-1/PD-L1 and
Chen R; Zhou X; Liu J; Huang G
Eur J Nucl Med Mol Imaging; 2019 Apr; 46(4):848-854. PubMed ID: 30627815
[TBL] [Abstract][Full Text] [Related]
17. Association between PD-L1 expression and
Choi YJ; Jo K; Hwang SH; Jeong Y; Lee JY; Kim S; Kim SW; Kim YT; Kang WJ
Ann Nucl Med; 2021 Apr; 35(4):415-420. PubMed ID: 33656683
[TBL] [Abstract][Full Text] [Related]
18. Negative Correlation Between
Wu L; Liu J; Wang S; Bai M; Wu M; Gao Z; Li J; Yu J; Liu J; Meng X
Front Endocrinol (Lausanne); 2022; 13():913631. PubMed ID: 35846323
[TBL] [Abstract][Full Text] [Related]
19. Relationship between SUVmax on 18F-FDG PET and PD-L1 expression in hepatocellular carcinoma.
Zhou X; Hu Y; Sun H; Chen R; Huang G; Liu J
Eur J Nucl Med Mol Imaging; 2023 Aug; 50(10):3107-3115. PubMed ID: 37147479
[TBL] [Abstract][Full Text] [Related]
20. The Future of Cancer Diagnosis, Treatment and Surveillance: A Systemic Review on Immunotherapy and Immuno-PET Radiotracers.
Liberini V; Laudicella R; Capozza M; Huellner MW; Burger IA; Baldari S; Terreno E; Deandreis D
Molecules; 2021 Apr; 26(8):. PubMed ID: 33920423
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]